CLGN
NASDAQ · Biotechnology
Collplant Biotechnologies Lt
$0.33
+0.01 (+3.48%)
Open$0.31
Previous Close$0.32
Day High$0.34
Day Low$0.30
52W High$3.18
52W Low$0.27
Volume—
Avg Volume100.9K
Market Cap6.02M
P/E Ratio—
EPS$-1.03
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+5,113.8% upside
Current
$0.33
$0.33
Target
$17.19
$17.19
$14.35
$17.19 avg
$29.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.55M | 1.78M | 1.91M |
| Net Income | -17,202,735 | -7,772,710 | 134.3K |
| Profit Margin | -484.6% | -460.3% | 7.0% |
| EBITDA | -15,826,882 | -7,548,339 | 222.2K |
| Free Cash Flow | — | — | 168.1K |
| Rev Growth | +99.2% | +99.2% | +10.4% |
| Debt/Equity | — | — | 0.39 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |